A new acellular tissue-engineered vessel developed by Vascudyne could provide surgeons with a safe, effective alternative to saphenous vein grafts.

Several U.S. medical societies have collaborated on a new report advocating for better safety standards in cardiac catheterization labs. As one cardiologist described it, clinicians have shifted from "accepting risk" to "expecting better."

Successfully adopting the technology across wide and varying care settings depends on a whole lot more than just technical sophistication. 

Targeting key cardiovascular risk factors for two full years was not linked to a reduced risk of cognitive decline or dementia.

The COVID-19 pandemic created a major shift in how telehealth services were being utilized. Those services were used much more often for some patient populations than others.

The federal regulatory agency that exists to protect consumers and promote competition across the economy is newly focused on patients and clinicians as well as taxpayers.  

The Cardiovascular Business Forty Under 40 Class of 2026 represents an accomplished group of clinicians, researchers, entrepreneurs and administrators who are redefining what cardiovascular leadership looks like under the age of 40. 

The next-generation valve from Corcym features a sutureless frame as well as laser-cut leaflets and thread holes.